key: cord-0803716-6c5tmnin authors: Wang, Chien-Chih; Chao, Jian-Kang; Wang, Mong-Lien; Yang, Yi-Ping; Chien, Chien-Shiu; Lai, Wei-Yi; Yang, Yi-Chiang; Chang, Yu-Hui; Chou, Chen-Liang; Kao, Chung-Lan title: Care for Patients with Stroke During the COVID-19 Pandemic: Physical Therapy and Rehabilitation Suggestions for Preventing Secondary Stroke date: 2020-07-22 journal: J Stroke Cerebrovasc Dis DOI: 10.1016/j.jstrokecerebrovasdis.2020.105182 sha: 4571751de374fd80adf69a81870e68a1bacf8a9c doc_id: 803716 cord_uid: 6c5tmnin Infection with the novel severe acute respiratory syndrome coronavirus 2 causes the development of the novel 2019 coronavirus disease (COVID-19) and associated clinical symptoms, which typically presents as an upper respiratory syndrome such as pneumonia. Growing evidence indicates an increased prevalence of neurological involvement (e.g., in the form of stroke) during virus infection. COVID-19 has been suggested to be more than a lung infection because it affects the vasculature of the lungs and other organs and increases the risk of thrombosis. Patients with stroke are vulnerable to secondary events as a result not only of their poor vascular condition but also of their lack of access to rehabilitation resources. Herein, we review current knowledge regarding the pathophysiology of COVID-19, its possible association with neurological involvement, and current drug therapies. Suggestions are also offered regarding the potential for current neurorehabilitation therapies to be taught and practiced at home. The outbreak of the novel coronavirus disease in Although no recent data have definitively indicated whether the rate of infection with COVID-19 has been higher among patients with stroke, comorbidities such as hypertension, diabetes, and cardiovascular disease have been reported to be closely related to increased infection rates among patients with stroke. 3, 4 Secondary stroke risk may be increased not only because of the thrombotic properties of COVID-19 but also because of physical inactivity resulting from isolation or restricted access to hospital facilities and therapy among these patients. This review discusses the relationship of COVID-19 to the neurological aspects of pathophysiology and immune responses. To address the current concerns regarding a lack of access to drug therapy, some neurorehabilitation techniques can potentially be taught and practiced at home. Coronaviruses are enveloped positive strand RNA viruses with the largest known RNA genome. 5, 6 The RNA genome of coronaviruses is highly variable and subject to recombination, which is a typical feature of RNA viruses. This feature enables them to quickly spread among humans and animals, sometimes leading to life-threatening conditions. However, some highly contagious and pathogenic strains are occasionally produced from recombination within intermediate hosts. The corona-like appearance with club-shaped spikes is the main feature of the virus. The nucleocapsids are helically symmetrical and are packed by the envelope of the virion. 6, 7, 8 Among the functions of the structural proteins, the envelope has a crucial role in virus pathogenicity through the promotion of viral assembly and release. 9 The pathogenic lesions of coronavirus infection arise mainly from immunopathological events that result in fatal pneumonia. 9 Pathogen-associated molecular patterns comprising viral RNA form during viral replication and trigger immune recognition. 10 This results in the expression of type I interferon and proinflammatory cytokines for protection against infection by the virus, which constitutes the early stage of defense against the virus. 11 In some severe cases, the cytokine storm induced by interleukin 6 (IL-6) causes massive tissue damage, characterized by fever and multiple organ dysfunction. 10 , 12 In addition, higher plasma levels of interleukin 2, interleukin 7, interleukin 10, GSCF, IP10, MCP1, MIP1A, and TNFα are observed in patients requiring admission to the intensive care unit. 13 Recent observations suggest that microvascular thrombolic processes may play a prominent role in respiratory failure induced by COVID-19. 14,15 Venous thrombosis is indicated by the strong association among disease progression embolus, D-dimer levels, and chest computed tomography features. 16 This infection-associated coagulopathy suggests that COVID-19 may be a thromboinflammatory process that initially affects lung perfusion and subsequently affects all organs of the body. 17 The renin-angiotensin system(RAS) in brain and peripheral organ played a fundamental role in regulating the electrolyte homeostatsis and cardiovascular control . 18 The classic axis with ACE(angiotensin) ,Angiotensin II(Ang II) and (CNS), and its expression has been shown to increase following stroke. 25 The coagulopathy of COVID-19 was initially reported through observation of the increased incidence of pulmonary embolism in highly symptomatic ill patients. 28 A link between thromboembolic events and influenza-associated pneumonia has been identified 29 .An increased procoagulant profile such as D-dimer level and fibrin degradation products was observed in patients with COVID-ARDS, and this coagulathy can be reversed after thromboprophylaxis prescription 30,31 Moreover , disseminated intravascular coagulopathy (DIC) characterized by severe thrombocytopenia and low platelet count due to the comsumption of coagulation factors was also found in severe COVID-19 patients. 32, 33 Vasculitis caused by the inflammation is considered to be an important mechanism in neurological manifestations. Previous reports on patients with SARS indicated widespread vascularity in many organs, 34 which may directly affect blood supply to the brain. Moreover, the presence of hypertension or hypotension was also considered to be a crucial factor related to the occurrence of cerebrovascular events. A study conducted in Singapore revealed that 5 of 206 patients with SARS had large vessel lesions, and 3 of them had severe episodes of hypotension. 35 Elevated blood pressure was also noted among a high proportion of critically ill patients and nonsurvivors. 1 Moreover, cardiac abnormality and arrhythmia contribute to increased stroke incidence, which may be caused by critical illnesses such as hypoxia, metabolic derangement, and systemic inflammation. 35 An increasing number of cases of sudden loss of olfactory function have been reported. A possible mechanism was proposed to be related to central cortical neurons and the expression of olfactory receptors possessing ACE2 receptors. 13 Although damage to primary epithelial cells was considered, MRI revealed no olfactory bulb or tract abnormalities that would indicate CNS involvement. 36 Musculoskeletal injury was also reported in recent Wuhan reports. Related muscle symptoms and injury were reported to be accompanied by marked elevation in creatine kinase and lactate dehydrogenase levels. 1 This injury could be associated with ACE2 expression in the musculoskeletal system, but the ACE2 receptor cannot be detected through autopsy sampling; therefore, further studies are required. 37, 38 However, a systemic immune response induced by infection may cause damage to skeletal muscle, as indicated by marked increases in proinflammatory cytokine levels in serum. 1 The lopinavir and ritonavir are HIV type I asparate protease inhibitors that have been found to be potent against SARS-CoV-2 in vitro. 39 with favipiravir demonstrated quicker recovery from fever and cough but similar rates of respiratory failure compared with a control group receiving umifenovir. 45 Hydroxychloroquine and chlorquine have demonstrated the ability to inhibit SARS-CoV-2 in vitro. 46, 47 Although treatment with hydroxychloroquine and azithromycin was significantly associated with decreased viral load in a small trial in France. 48 the therapeutic effect remains questionable because it failed to eliminate the virus or significantly relieve symptoms in a recent randomized controlled trial conducted in China. 49 Finally, tocilizumab, a humanized monoclonal antibody against the IL-6 receptor that was traditionally used to treat patients with rheumatoid arthritis, has also been approved for use in China. 50 Notably, immunomodulatory agents such as tocilizumab increase the risk of opportunistic infections. 51 Cardiac toxicity, including long QT syndrome and conduction abnormalities, is a notable effect of hydrochroquine and chroquinine application. 52, 53 Tocilizumab and other IL-6 receptor antagonists may also increase CV risk by inducing unfavorable changes in lipid profiles. 54 The continued use of ACE and angiotensin-receptor blockers is still suggested because switching to another medication incurs a higher risk than that associated with infection, especially for hypertension management in patients with stroke. 55 Because physical therapy and rehabilitation are inaccessible resources during pandemics, neurorehabilitation often cannot be offered to patients with stroke on the same scale as it can during pandemic-free conditions, especially during the acute and subacute phases; consequently, patients may be prevented from reaching the optimal recovery phase. Studies have indicated that prolonged immobility among patients with stroke may result in significant functional decline 56 Thus, some strategies for facilitating neurorehabilitation may be applied in the absence of assistance from physical and occupational therapists. Several potential techniques can be used to stimulate neurorestoration and maintain muscle strength with minimal assistance; these are listed as follows. 57 Poststroke spasticity in lower limbs can be effectively reduced by TENS when applied for more than 30 minutes over a nerve or muscle belly in patients with chronic stroke. 59 In addition, peripheral nerve stimulation at ulnar and radial sites for 1 h has been revealed to increase corticomotor function and improve hand dexterity in patients with moderate to severe hemiparesis. 60 Thus, TENS may be utilized as a convenient tool for temporal function and muscle facilitation to maintain therapeutic effects with the provision of proper assistance. Prolonged periods of sensory stimulation, such as TENS combined with activity, can have beneficial effects for treating impaired function after stroke. Mirror therapy (MT) has been proven to be an effective and feasible approach for rehabilitating patients who have had a stroke. 61 MT utilizes a mirror that reflects the movement of an unaffected limb and gives the illusion of movement of the affected limb. This visual stimulus is believed to facilitate the mirror neurons involved in imitative learning through interaction with the neural motor area. 62 MT was also reported to ameliorate an imbalance in function of the cortical excitability hemisphere. 62 MT was found to confer a significant positive effect on motor function when applied for 15 to 60 minutes per session over the course of 2 to 8 weeks. 63 The application time is adjustable to acute, subacute, and chronic cases of stroke. 61 The mirror is normally positioned between the affected and unaffected limbs such that the movement of the healthy limb is perceived as the movement of the unaffected limb. The entire procedure is straightforward to execute through simple instruction and can be performed under minimal supervision. Increasing evidence suggests that the implementation of home-based exercise is noninferior to outpatient courses. 64 Home-based locomotion training with physical therapists can achieve the target response with the same efficiency as outpatient courses among patients with stroke. 65 Mayo et al found that combined cycle and supervised walking training at home successfully improved patient's long-term walking ability. 66 Although most home-based exercise programs must be supervised by a therapist, some exercises can be performed smoothly with assistance from properly instructed family members. The application of virtual reality (VR) is increasingly being used in stroke rehabilitation. 67 Several studies have demonstrated that VR technology can improve motor functioning. 68 VR can also be used to improve upper limb function, gait and balance, global motor function, and cognitive function in patients with stroke. 69 However, VR equipment is usually expensive and complex and may only be available in specialist hospitals. The Nintendo Wii system supplemented with a balance board and a bar enabling body movement in a VR game environment could be a viable option for use in treatment for patients with stroke. It was shown to be useful as an adjunct therapy to traditional treatment in improving dynamic balance in patients who have had a stroke. 70 The COVID-19 pandemic has not only had a direct impact on people's health but also has greatly influenced public access to hospitals, which may prevent patients who have had a stroke from receiving standard rehabilitation therapy. In this review, we summarize the neurological manifestations of COVID-19 described in the accumulating reports that may lead to neurological complications in patients with stroke. The ACE2 receptor is crucial in viral transmission, but it is still not recommended that patients stop using ACE or angiotensin-receptor-blocker drugs essential for hypertension control. For the current choice in anti-COVID19 medication, we advise practitioners to be aware of the cardiovascular or infection risks associated with hydroxychloquine or immunomodulatory agents such as tocilizumab. Portable devices such as TENS devices can be easily used to maintain muscle strength and reduce spasticity at home when access to hospitals is limited. A combination of basic home exercises with VR implemented by video game consoles such as Wii may also be a feasible technique for maintaining physical balance and protecting functional deterioration. This work was financially supported by Taipei Veterans General Hospital, Yuli branch Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 -United States Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory medicine Mechanisms of coronavirus cell entry mediated by the viral spike protein Emerging coronaviruses: Genome structure, replication, and pathogenesis Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor Coronavirus Diseases Current Status and Future Perspectives: A Narrative Review A Review of SARS-CoV-2 and the Ongoing Clinical Trials Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic Interleukin-6 Family Cytokines. Cold Spring Harbor perspectives in biology Clinical features of patients infected with 2019 novel coronavirus in Wuhan Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Translational research : the journal of laboratory and clinical medicine Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected by Pulmonary CT Angiography Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands Role of brain renin angiotensin system in neurodegeneration: An update. Saudi journal of biological sciences Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights Therapeutic potential of the renin angiotensin system in ischaemic stroke. Experimental & translational stroke medicine SARS-CoV-2 invades host cells via a novel route: CD147-spike protein New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Angiotensin Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System Neuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in stroke Cerebroprotective action of thrombosis and haemostasis : JTH Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clinical chemistry and laboratory medicine The clinical pathology of severe acute respiratory syndrome (SARS): a report from China Large artery ischaemic stroke in severe acute respiratory syndrome (SARS) Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19. JAMA otolaryngology--head & neck surgery Renin-angiotensin system: an old player with novel functions in skeletal muscle Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. The New England journal of medicine The coronavirus pandemic in five powerful charts Compassionate Use of Remdesivir for Patients with Severe Covid-19. The New England journal of medicine Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial. medRxiv Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial. medRxiv Clinical trial analysis of 2019-nCoV therapy registered in China Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature Tocilizumab and the Risk of Cardiovascular Disease: Direct Comparison Among Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Patients Renin-angiotension-aldosterone system, urinary prostaglandins and kallikrein in pregnancy-induced hypertension: evidence for a dysregulation of the renin-angiotensin-prostacyclin loop The effect of rehabilitation interventions on physical function and immobility-related complications in severe stroke-protocol for a systematic review Adding electrical stimulation during standard rehabilitation after stroke to improve motor function. A systematic review and meta-analysis. Annals of physical and rehabilitation medicine Effects of sit-to-stand training combined with transcutaneous electrical stimulation on spasticity, muscle strength and balance ability in patients with stroke: A randomized controlled study Effect of Transcutaneous Electrical Nerve Stimulation on Spasticity in Adults With Stroke: A Systematic Review and Meta-analysis. Archives of physical medicine and rehabilitation Corticomotor Excitability Effects of Peripheral Nerve Electrical Stimulation to the Paretic Arm in Stroke. American journal of physical medicine & rehabilitation Mirror Therapy in Stroke Rehabilitation: Current Perspectives. Therapeutics and clinical risk management The mirror neuron system in post-stroke rehabilitation. International archives of medicine Mirror therapy for improving motor function after stroke. The Cochrane database of systematic reviews Stroke Rehabilitation at Home: Lessons Learned and Ways Forward Body-weight-supported treadmill rehabilitation after stroke. The New England journal of medicine A randomized trial of two home-based exercise programmes to improve functional walking post-stroke Virtual Reality Reflection Therapy Improves Balance and Gait in Patients with Chronic Stroke: Randomized Controlled Trials. Medical science monitor : international medical journal of experimental and clinical research Virtual reality therapy for upper limb rehabilitation in patients with stroke: a meta-analysis of randomized clinical trials Virtual reality for stroke rehabilitation. The Cochrane database of systematic reviews Effectiveness of Wii-based rehabilitation in stroke: A randomized controlled study Physician Scientists Cultivation Program No. 108-V-B-008 The authors have no competing interests to declare.